Use of Multigene Panel Germline Sequencing to Identify a Thyroid Cancer Predisposition

Clinical Thyroidology®Vol. 35, No. 6 Thyroid CancerUse of Multigene Panel Germline Sequencing to Identify a Thyroid Cancer PredispositionDan Moldoveanu and Jesse D. PasternakDan MoldoveanuEndocrine Surgery Section, Division of General Surgery, University Health Network, University of Toronto, Toronto, Ontario, Canada.Search for more papers by this author and Jesse D. PasternakEndocrine Surgery Section, Division of General Surgery, University Health Network, University of Toronto, Toronto, Ontario, Canada.Search for more papers by this authorPublished Online:13 Jun 2023https://doi.org/10.1089/ct.2023;35.236-238AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 35Issue 6Jun 2023 Information© Copyright 2023, Mary Ann Liebert, Inc.To cite this article:Dan Moldoveanu and Jesse D. Pasternak.Use of Multigene Panel Germline Sequencing to Identify a Thyroid Cancer Predisposition.Clinical Thyroidology®.Jun 2023.236-238.http://doi.org/10.1089/ct.2023;35.236-238Published in Volume: 35 Issue 6: June 13, 2023PDF download